Pregled bibliografske jedinice broj: 874074
Papillary fibroelastomas – 15 years single-centre case series and brief review of the literature
Papillary fibroelastomas – 15 years single-centre case series and brief review of the literature // Cardiologia Croatica 2017 ; 12(4):152. / Ivanuša, Mario (ur.).
Zagreb: Hrvatsko kardiološko društvo, 2017. str. 152-152 (poster, domaća recenzija, sažetak, stručni)
CROSBI ID: 874074 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Papillary fibroelastomas – 15 years single-centre case series and brief review of the literature
Autori
Dalmatin, Rina ; Bastiančić, Luka ; Zaninović Jurjević, Teodora ; Žagar, Davorka ; Zaputović, Luka ; Ružić, Alen
Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, stručni
Izvornik
Cardiologia Croatica 2017 ; 12(4):152.
/ Ivanuša, Mario - Zagreb : Hrvatsko kardiološko društvo, 2017, 152-152
Skup
9. Croatian Echocardiography Meeting with International participation
Mjesto i datum
Poreč, Hrvatska, 04.05.2017. - 06.05.2017
Vrsta sudjelovanja
Poster
Vrsta recenzije
Domaća recenzija
Ključne riječi
cardiac tumors, cardiac surgery, echocardiography
Sažetak
Introduction: Cardiac tumors are extremely rare with the incidence <0.1%, found in approximately 7 of 12.000 autopsies. Papillary fibroelastomas (PFs) are the second most common benign cardiac tumors, peduncular and mobile, typically speckled and echolucent. The mean patient age at detection is 60 years. According to the literature 1-3, PFs are most commonly seen at the aortic (36%) and mitral (29%) valve, while they can be found on the tricuspid valve in 11% cases or at the pulmonic valve in 7% patients. These benign cardiac tumors usually (70%) have symptoms and they are mostly due to embolization, either of tumor itself or the tumor associated thrombus. Methods and Results: From 2002 till today, at the Department of Cardiovascular Diseases at University Hospital Centre Rijeka, we found 9 cases of PFs that have been patohystologically proven. The PFs were most often finded at the aortic valve (4 cases), in 2 cases they were situated at the pulmonary valve and the same was the number of PFs found at the mitral valve, while only one was found at the tricuspid valve. Only 2 cases were completely asymptomatic, while 7 had symptoms probably related to PFs: 4 of them had cerebral embolic symptoms and in 3 cases the coronary embolism was suspected. In only one case the tumor had hemodynamic implications by reducing the effective mitral valve area. In our series, 6 patients with PFs were sent to cardiac surgery, and in 3 cases the observation was indicated. Conclusion: PFs are rare benign cardiac tumors with a high embolic potential. The surgery is reasonable therapeutic option for all patients at risk of embolization or in those with other indications for heart surgery. Nowdays, the PFs of the left heart should be considered for operation, while those at the pulmonary and tricuspid valve are removed only in case of surgical revascularization, aortic aneurysm correction or other heart valve disease that is hemodinamically significant. The global PFs registry is needed for better understanding of PFs.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti
POVEZANOST RADA
Ustanove:
Medicinski fakultet, Rijeka,
Klinički bolnički centar Rijeka
Profili:
Teodora Zaninović Jurjević
(autor)
Luka Zaputović
(autor)
Alen Ružić
(autor)
Davorka Žagar
(autor)